Amanote Research
Register
Sign In
305. Development of a qPCR Based Assay for Assessing Integrity of Oversized AAV Vectors
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35318-7
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
92. Evaluation of Producer Cell Line Platform for Production of Oversized AAV-FVIII Vectors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
310. Development of Generation X Recombinant AAV Vectors for Human Gene Therapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
247. Characterization of Oversized rAAV Vectors for Human FVIII Gene Transfer
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
681. rDNA-AAV Vectors for the Treatment of Phenylketonuria
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Production and Characterization of Vectors Based on the Cardiotropic AAV Serotype 9
Methods in Molecular Biology
Genetics
Molecular Biology
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
Detection of Ochratoxin a by Aptamer-Assisted Real-Time PCR-based Assay (Apta-qPCR)
Engineering in Life Sciences
Bioengineering
Environmental Engineering
Biotechnology
309. Optimization of Dual AAV Vectors for Gene Therapy of Inherited Retinal Diseases
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Engineered AAV Vectors for Improved Central Nervous System Gene Delivery
Neurogenesis
Developmental Neuroscience
Developmental Biology